Sarepta Therapeutics (SRPT) Long-Term Investments (2013 - 2026)
Sarepta Therapeutics' quarterly Long-Term Investments came in at $81.9 million in Q1 2026, down 46.92% year-on-year from $154.4 million in Q1 2025, and up 760.67% quarter-over-quarter from $9.5 million in Q4 2025.
Sarepta Therapeutics has reported Long-Term Investments for 14 years, with the latest figure at $81.9 million in Q1 2026.
- For the quarter ending Q1 2026, Long-Term Investments fell 46.92% year-over-year to $81.9 million; the trailing twelve-month figure through Mar 2026 stood at $81.9 million (down 46.92% YoY), and the FY2025 full-year result was $9.5 million, down 92.85% from the prior year.
- Long-Term Investments for Q1 2026 stood at $81.9 million, up from $9.5 million in the prior quarter.
- The five-year high for Long-Term Investments was $181.8 million in Q3 2024, with the low at $1.0 million in Q3 2025.
- Average Long-Term Investments over 5 years is $47.6 million, with a median of $19.0 million recorded in 2022.
- Peak annual rise in Long-Term Investments reached 1970.14% in 2025, while the deepest fall reached 99.43% in 2025.
- Tracing SRPT's Long-Term Investments over 5 years: stood at $31.3 million in 2022, then sank by 39.02% to $19.1 million in 2023, then jumped by 597.19% to $133.2 million in 2024, then tumbled by 92.85% to $9.5 million in 2025, then jumped by 760.67% to $81.9 million in 2026.
- The last three Long-Term Investments figures came in at $81.9 million (Q1 2026), $9.5 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 505,194.89 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 5.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.79 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 22.17 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 81.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.94 Mn |
| Dec 31, 2025 | 9.52 Mn |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 34.60 Mn |
| Mar 31, 2025 | 154.37 Mn |
| Dec 31, 2024 | 133.16 Mn |
| Sep 30, 2024 | 181.77 Mn |
| Jun 30, 2024 | 7.61 Mn |
| Mar 31, 2024 | 7.46 Mn |
| Sep 30, 2023 | 19.10 Mn |
| Jun 30, 2023 | 19.00 Mn |
| Mar 31, 2023 | 19.00 Mn |
| Dec 31, 2022 | 31.32 Mn |
| Sep 30, 2022 | 19.00 Mn |
| Jun 30, 2022 | 33.23 Mn |
| Mar 31, 2022 | 9.70 Mn |
| Dec 31, 2021 | 9.90 Mn |
| Sep 30, 2021 | 9.30 Mn |
| Jun 30, 2021 | 39.97 Mn |
| Mar 31, 2021 | 9.30 Mn |
| Dec 31, 2020 | 9.32 Mn |
| Sep 30, 2020 | 9.60 Mn |
| Jun 30, 2020 | 9.60 Mn |
| Mar 31, 2020 | 9.57 Mn |
| Dec 31, 2019 | 9.57 Mn |
| Sep 30, 2019 | 9.57 Mn |
| Jun 30, 2019 | 32.15 Mn |
| Mar 31, 2019 | 6.20 Mn |
| Dec 31, 2018 | 31.74 Mn |
| Sep 30, 2018 | 30.00 Mn |
| Jun 30, 2018 | 1.00 Mn |
| Mar 31, 2018 | 784,000.00 |
| Dec 31, 2017 | 21.81 Mn |
| Sep 30, 2017 | 784,000.00 |
| Jun 30, 2017 | 784,000.00 |
| Mar 31, 2017 | 784,000.00 |
| Dec 31, 2016 | 784,000.00 |
| Sep 30, 2016 | 784,000.00 |
| Jun 30, 2016 | 783,000.00 |
| Mar 31, 2016 | 783,000.00 |
| Dec 31, 2015 | 783,000.00 |
| Sep 30, 2015 | 11.48 Mn |
| Jun 30, 2015 | 783,000.00 |
| Mar 31, 2015 | 783,000.00 |
| Dec 31, 2014 | 782,000.00 |
| Sep 30, 2014 | 647,000.00 |
| Jun 30, 2014 | 647,000.00 |
| Mar 31, 2014 | 647,000.00 |
| Dec 31, 2013 | 647,000.00 |
| Sep 30, 2013 | 557,000.00 |
| Jun 30, 2013 | 557,000.00 |
| Mar 31, 2013 | 7.25 Mn |